Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Alacepril (DU-1219) is a relatively novel angiotensin-converting enzyme inhibitor, used as an antihypertensive
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
10 mg | 在庫あり | ¥ 11,500 | |||
25 mg | 在庫あり | ¥ 18,500 | |||
50 mg | 在庫あり | ¥ 28,000 | |||
100 mg | 在庫あり | ¥ 42,000 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 13,000 |
説明 | Alacepril (DU-1219) is a relatively novel angiotensin-converting enzyme inhibitor, used as an antihypertensive |
In vivo | Treatment with alacepril improves functional status and exercise capacity in patients with mild-to-moderate CHF. Neurohormones were favourably influenced by alacepril therapy, with significant decreases in plasma aldosterone, ANP and BNP levels[1]. |
別名 | Cetapril, DU-1219 |
分子量 | 406.5 |
分子式 | C20H26N2O5S |
CAS No. | 74258-86-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 27.5 mg/mL (67.65 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Alacepril 74258-86-9 Endocrinology/Hormones RAAS Cetapril antihypertensive effect DU1219 Inhibitor oral long lasting DU 1219 inhibit Angiotensin-converting Enzyme (ACE) DU-1219 inhibitor